Frequency of Thrombophilia Genes in Patients with Chronic Myeloproliferative Disease

I.V. Berger^1, , A.D. Makhmudova¹, A.A. Kayumov¹ and M.O. Omonov¹

¹Republican Specialized Scientific and Practical Medical Center of Hematology, Tashkent, Uzbekistan

Cite this paper:
I.V. Berger, A.D. Makhmudova, A.A. Kayumov and M.O. Omonov. Frequency of Thrombophilia Genes in Patients with Chronic Myeloproliferative Disease. American Journal of Medical Sciences and Medicine. 2023; 11(4):102-105. doi: 10.12691/ajmsm-11-4-2

Abstract

Introduction. The danger of thrombosis for humans has become widely known since the mid-nineteenth century, and the list of diseases whose pathogenesis involves the formation of blood clots includes most of the known nosological forms today. The purpose of the work was to study the frequency of occurrence and allelic load of mutations in thrombophilia genes in patients with chronic myeloproliferative diseases. Materials and methods. 50 patients with chronic myelopolyferative diseases (CMPD), age less than 50 years and episodes of thrombosis were examined in the inpatient conditions of the Russian National Research Medical Center for Hematology. Conclusions: The high frequency of mutations of thrombophilia genes in patients with CMРD indicates the possible participation of genes of a hereditary nature in the development of thrombosis and the outcome of the underlying disease.

Keywords:
thrombophilia genetic testing myeloproliferative diseases polycythemia vera essential thrombocytosis myelofibrosis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Ramzi M., N. Cohan, M. Yavarian, M.R. Jahromi // Coagulation factor VII gene polymorphisms and cardiovascular diseases in Iranian population / J. Indian College of Cardiology. 2013. Vol. 3, No 1. P. 6-8.
[2]	Melikyan A.L., A.G. Turkina, K.M. Abdulkadyrov [et al.] /Clinical recommendations for the diagnosis and treatment of Ph-negative myeloproliferative diseases (polycythemia vera, essential thrombocythemia, primary myelofibrosis) // Hematology and transfusiology. - 2014. - T. 59, No. 4. -S. 31-56.
[3]	Martiskainen M., Pohjasvaara T., Mikkelsson J. Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke // Stroke.- 2020.- V. 34, N 4.- P. 886-891.
[4]	Rosendaal F.R., Siscovick D.S., Schwartz S.M. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women // Blood.- 2017.- V. 90, N 5.- P. 1747-1750.
[5]	Friptu Valentin, Mitriuc Diana, Popusoi Olga HEREDITARY THROMBOPHILIA AND ADVERSE PREGNANCY OUTCOMES // The Moldovan Medical Journal. 2021. №3. URL: https://cyberleninka.ru/article/n/hereditary-thrombophilia-and-adverse-pregnancy-outcomes.
[6]	Abdulbary A.M. Ahmed, Azova M. Madina ASSOCIATION OF VEGFA, FACTOR V AND PROTHROMBIN GENE POLYMORPHISMS WITH EARLY PREGNANCY LOSS // Scientific results of biomedical research. 2021.
[7]	Duangnapasatit D., E. Rattarittamrong, T. Rattanathammethee/ Clinical Manifestations and Risk Factors for Complications of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms //Asian Pac J Cancer Prev. - 2015. - Vol. 16(12). - P. 5013-5018.
[8]	Butt C., Zheng H., Randell E. e.a. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction // Blood.- 2021.- V.102, N 4.- P. 1558-1559.
[9]	Mahmoodi , , , , , , , . Venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin J Thromb Haemost. 2018 Jun; 8(6): 1193-200.
[10]	Andreenko E.Yu., L.M. Samokhodskaya, A.V. Balatsky, P.I. Makarevich, S.A. Boytsov //Prognostic significance of carriage of allelic variants of genes that control the hemostasis system, and their combination with traditional risk factors in the early development of coronary heart disease/Cardiovascular therapy and prevention. 2011. T. 10, No. 8. P. 32-39.